3M Drug Delivery Systems Spring Show Guide - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

3M Drug Delivery Systems Spring Show Guide

For pharmaceutical and biotech companies seeking innovation, quality and performance, 3M is the global expert in manufacturing from start-to-finish. See us at Interphex New York (April 23-25), booth # 2143, to find how trusted inhalation and transdermal drug delivery technologies from 3M can meet your product needs!

3M Drug Delivery Systems, St. Paul, MN |  www.3M.com/DDS  | tel. 800-643-8086

Shows attending:

  • PDA (Nov 5-6 in Switzerland) — (Booth 76)
  • BIO (attending, but no booth)
  • Interphex (Apr 23-25 NY) — Booth 2143
  • AAPS Biotech (Nov 10-14 TX) — Booth 4023
  • RDD (May 21-24 Berlin) — Booth TBD
  • MD&ME June 18-20 — Booth 3511
  • CRS (July 21-24 Hawaii — Booth 113
  • PODD (Oct 10-11 Boston) — Booth TBD
  • World Vaccine Congress (Oct 16-17) — Booth TBD
  • DDS (Dec 11-13 Edinburgh, UK) — Booth TBD


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns

Click here